Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes

NCT05683990 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Autoimmune Diseases
Prevention

Interventions

DRUG: Diamyd

Sponsor

Diamyd Medical AB